| 000 | 01655 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517060020.0 | ||
| 264 | 0 | _c20160829 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1769-6690 | ||
| 024 | 7 |
_a10.1016/j.medmal.2015.09.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBachoumas, K | |
| 245 | 0 | 0 |
_aFatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin. _h[electronic resource] |
| 260 |
_bMedecine et maladies infectieuses _cOct 2015 |
||
| 300 |
_a417-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xchemically induced |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 |
_aFusidic Acid _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOsteitis _xdrug therapy |
| 650 | 0 | 4 |
_aPravastatin _xadverse effects |
| 650 | 0 | 4 |
_aRhabdomyolysis _xchemically induced |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 | _aTibia |
| 700 | 1 | _aFiancette, M | |
| 700 | 1 | _aLascarrou, J-B | |
| 700 | 1 | _aLacherade, J-C | |
| 700 | 1 | _aLeclair, F | |
| 700 | 1 | _aReignier, J | |
| 773 | 0 |
_tMedecine et maladies infectieuses _gvol. 45 _gno. 10 _gp. 417-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.medmal.2015.09.006 _zAvailable from publisher's website |
| 999 |
_c25359007 _d25359007 |
||